FRIDAY, DECEMBER 13

Business, Economics, and Regulations in Urology

Deepak A. Kapoor, MD

Lancet Commission on Prostate Cancer

Nick James (Prof) MBBS, PhD

Online Misinformation About Prostate Cancer

Stacy Loeb, MD, PhD (Hon)

Should We Keep Calling ISUP 1 Prostate Cancer?

Ming Zhou, MD, PhD

State-of-the-Art Lecture on Multicancer Early Detection

Eric Klein, MD

How to Use Polygenic Risk Ratios in Stratifying Patients for Prostate Cancer

Sujit Nair, PhD

Q&A

TP Biopsy- The New Standard of Care

Jim Hu, MD, MPH

Use of Testosterone Replacement Therapy in Patients on Active Surveillance and Post PCa Treatment

Leon Telis, MD

Active Surveillance: When to Intervene and the Role of Imaging and Genomics

Peter Pinto, MD

Genomics and Clinical Significance of MR Visible vs Invisible Cancers

Laurence Klotz, CM, MD

Use of Biplanar vs mpMRIs for Diagnosis of Early Prostate Cancer

Samir S. Taneja, MD

Use of PSMA in Active Surveillance Risk Stratification - HOLOGRAM

Declan Murphy, MB, FRCS

Lunch / Visit Exhibits

Update on Prostatic Intra-Acinar Neoplasia: Precursors and Beyond

Angelo M. De Marzo, MD, PhD

Emerging Mechanisms of Treatment Resistance in Advance Prostate Cancer

Himisha Beltran, MD, FRCS

Biology of Prostate Cancer Metastases: Implications for Treatment

Simpa Salami, MD, MPH

Neoadjuvant Apalutamide and Downstaging Prostate Cancer

Isaac Kim, MD, PhD

Surgeon Scientist Journey in Advanced Prostate Cancer 

Martin Gleave, MD

Q&A

Moderator: Isaac Kim, MD

Panel: Himisha Beltran, MD;  Richard Stock, MD; Sujit Nair; PhD

National Prostate Cancer Screening in Sweden

Anna Lantz, MD, PhD

German Prostate Cancer Screening Trial PROBASE

Peter Albers, MD

Oncological Outcomes after Lymph Node Dissection vs No LND for High Risj Prostate Cancer 

Peter Wiklund, MD, PhD

Intensification versus De-Intensification Strategies in Prostate Cancer

Neal Shore, MD, FACS

Prostate Cancer: Navigating the Landscape from HS to CRPC

Cora Sternberg, MD, FACP

The Evolving Management of Small Renal Masses: Advances in Active Surveillance and Future Perspectives

Craig Rogers, MD

Mastering Surgical Skills: The Science of Proficiency-Based Progression Training

Alexandre Mottrie, MD, PhD

Overview of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma

Brian Shuch, MD

Modern Approach to Robotic Partial Nephrectomy for Hilar Tumors

Jihad Kaouk, MD

Q&A 

Closing Remarks 

Ketan Badani, MD, FRCS